GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

GE

255.78

+1.67%↑

RTX

139.19

+0.19%↑

CAT

353.42

+1.42%↑

BA

210.99

+0.98%↑

HON

228.84

+1.06%↑

Search

India Globalization Capital Inc

Fechado

0.3

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.3

Máximo

0.31

Indicadores-chave

By Trading Economics

Rendimento

-112K

-1.8M

Vendas

-155K

257K

Margem de lucro

-711.673

Funcionários

67

EBITDA

-106K

-1.7M

Dividendos

By Dow Jones

Próximos Ganhos

20 de jun. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

25M

Abertura anterior

0.3

Fecho anterior

0.3

India Globalization Capital Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de set. de 2024, 04:00 UTC

Principais Notícias

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

Comparação entre Pares

Variação de preço

India Globalization Capital Inc Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.